These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4804224)

  • 21. Single-dose pharmacokinetic study of 900 mg fenbufen in the elderly.
    Braverman AM
    Eur J Rheumatol Inflamm; 1982; 5(3):304-7. PubMed ID: 7084292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and excretion of furobufen in rats and dogs.
    Cayen MN; Ferdinandi ES; Greselin E
    Drug Metab Dispos; 1981; 9(2):125-8. PubMed ID: 6113110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of aspirin with nonsteroidal antiinflammatory drugs in man.
    Rubin A; Rodda BE; Warrick P; Gruber CM; Ridolfo AS
    Arthritis Rheum; 1973; 16(5):635-45. PubMed ID: 4582611
    [No Abstract]   [Full Text] [Related]  

  • 25. Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration.
    Rubin A; Rodda BE; Warrick P; Ridolfo AS; Gruber CM
    J Pharm Sci; 1972 May; 61(5):739-45. PubMed ID: 5035782
    [No Abstract]   [Full Text] [Related]  

  • 26. Disposition of furobufen in mice, rats, dogs, and man.
    Cayen MN; Kraml M; Robinson WT; Dvornik D
    Drug Metab Dispos; 1981; 9(2):119-24. PubMed ID: 6113109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous absorption of piketoprofen in rabbits: effect of nonionic surface-active agents.
    Fabregas JL; Cucala J; Segura J; Tarrus E
    Farmaco Prat; 1986 May; 41(5):177-83. PubMed ID: 3487466
    [No Abstract]   [Full Text] [Related]  

  • 28. Naproxen absorption in children.
    Ansell BM; Hanna DB; Stoppard M
    Curr Med Res Opin; 1975; 3(1):46-50. PubMed ID: 1167825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemical study on the pharmacokinetics of propiramfumarate].
    Pütter J; Kroneberg G
    Arzneimittelforschung; 1974 Apr; 24(4):643-51. PubMed ID: 4406767
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mass-spectrometric analysis of 2-aminobenzophenone derivatives and their metabolites].
    Golovenko NIa; Zin'kovskiĭ VG; Andronati SA; Iavorskiĭ AS
    Bioorg Khim; 1986 May; 12(5):686-94. PubMed ID: 3730010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological disposition of fenoprofen in man. 3. Metabolism and protein binding of fenoprofen.
    Rubin A; Warrick P; Wolen RL; Chernish SM; Ridolfo AS; Gruber CM
    J Pharmacol Exp Ther; 1972 Nov; 183(2):449-57. PubMed ID: 5083556
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent].
    Pfeifer S; Bornschein I; Gehrke A
    Pharmazie; 1977 Oct; 32(10):587-92. PubMed ID: 607217
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A; Hirota T; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of peptido-aminobenzophenone (2-o-chlorobenzoyl-4-chloro-N-methyl-N'-glycyl-glycinanilide) in dogs.
    Sato T; Konishi M; Ago T; Nakagawa Y; Iwatani K; Mori Y
    Xenobiotica; 1980 Feb; 10(2):125-33. PubMed ID: 6104877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on anti-inflammatory agents. XXXII. Absorption, excretion, distribution and metabolism of 2-(5H-(1)benzopyrano(2,3-b)pyridin-7-yl)propionic acid (Y-8004) in rats and mice (author's transl)].
    Kato Y; Arima N; Nishimine H
    Yakugaku Zasshi; 1976 Jul; 96(7):819-26. PubMed ID: 987220
    [No Abstract]   [Full Text] [Related]  

  • 37. [Activity of the antirheumatic benzofenac VUFB, in experimental animals and man, in relation to the species specificity of pharmacokinetics and biotransformation].
    Grimová J; Roubal Z; Koruna I; Nĕmecek O
    Cas Lek Cesk; 1982 Sep; 121(34-35):1078-82. PubMed ID: 7127389
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic and pharmacokinetic studies with fenbufen in man.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):728-35. PubMed ID: 7192124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pharmacokinetics of Z-2-amino-5-chlorobenzophenoneamidinohydrazone in the rat].
    Schieweck A; offchert HH; Morgenroth U; Joram U
    Pharmazie; 1993 May; 48(5):370-3. PubMed ID: 8327566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)].
    Farker K; Henschel L; Marschner JP; Reimann I; Volkmann H; Hoffmann A
    Pharmazie; 1993 May; 48(5):373-80. PubMed ID: 8327567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.